Navigation Links
Michael L. Eskew Elected to Lilly Board of Directors
Date:2/19/2008

Company Also Announces That George M.C. Fisher Will Retire from the Lilly

Board

INDIANAPOLIS, Feb. 19 /PRNewswire-FirstCall/ -- The Board of Directors of Eli Lilly and Company (NYSE: LLY) has elected Michael L. Eskew, former chairman and chief executive officer of United Parcel Service, Inc. (UPS), as a new member, effective February 18, 2008. Eskew will stand for election by the shareholders at the 2008 annual meeting in April.

Eskew, who served as chairman and chief executive officer of UPS from January, 2002 until December, 2007, brings over 35 years of global corporate management experience to the Lilly board.

"We are very pleased to welcome Mike Eskew to the Lilly board," said Sidney Taurel, Lilly chairman and chief executive officer. "His extensive management experiences and his outstanding track record of leadership in a customer-centered organization such as UPS ideally suit him to provide guidance and oversight to Lilly as it transforms itself into a truly patient- centered enterprise. Mike's experience as a board member of other leading American companies will also serve our company well."

Eskew, 58, began his UPS career in 1972 as an industrial engineering manager. After several global assignments with increasing responsibility, he was named corporate vice president for industrial engineering in 1993. In 1996 he became group vice president for engineering, and in 1998, he was elected to the UPS Board of Directors. In 1999, Eskew was named executive vice president and a year later was given the additional title of vice chairman. Eskew serves as a trustee of The UPS Foundation and as the chairman of the Board of Trustees of The Annie E. Casey Foundation. He also serves on the boards of directors of UPS, the 3M Corporation and IBM.

Lilly also announced that George M.C. Fisher, 67, will retire from the company's board of directors at the expiration of his current term, which ends on April 21, 2008. Fisher, the former chairman of the board and chief executive officer of both Motorola, Inc. and Eastman Kodak Company, has served on the Lilly board since 2000. Fisher is currently a senior advisor for Kohlberg Kravis Roberts & Company, is the presiding director of General Motors Corporation, and is a director of Visant Corporation.

"George has been an invaluable source of guidance and leadership during his time on the Lilly board, and he has served our company and its shareholders extraordinarily well during a very challenging period. Both the company and I personally have benefited from his insights, and we thank him for his service to Lilly and wish him well," said Taurel.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
4. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
5. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
6. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
7. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
10. Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
11. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that ... clinical and commercial support services market) has entered into an agreement on September ... , The PGSD is the first private Dental School to launch an ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic ... National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, ... when Athletic Trainers are acknowledged by their peers with accolades and highly prestigious ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were selected ... different categories. Nopavera Plus was named to the short list in the ... West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay ...
(Date:9/20/2017)... ... ... Health & Safety Institute (HSI) is offering discounted pricing on its Summit ... now until November 30, 2017 to assist with the clean-up efforts from hurricanes Harvey ... and government agencies – whether or not they will be directly involved in the ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED Ezekiel's Plan for Freedom ... Freedom from ADDICTION” is the creation of published author, Bill Miller. Bill ... homeless services, including more than a decade of addiction to prescription drugs. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: